首页 > 市场调查报告书 > 医疗设备

整形外科美容整形

市场调查报告书

商品编码

1439470

乳房重建 - 全球市场回顾、竞争格局、市场预测 (2030)

Breast Reconstruction - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 按订单生产 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

简介目录图表

预计2023年全球乳房重建市场规模将达5.545亿美元，2030年将达到8.1014亿美元，2024-2030年预测期间复合年增长率为6.54%。乳癌盛行率上升、整容和重建手术数量增加、采用先进技术的乳房重建产品推出迅速增加、人口老龄化以及种族和民族因素等因素正在推动对乳房的需求重建，市场因此呈现正增长。因此，预计在 2024-2030 年预测期内，乳房再造市场将以显着的复合年增长率成长。

乳房重建市场动力

乳房重建市场的主要驱动因素之一是全球乳癌盛行率的不断上升。根据世界卫生组织（WHO）2023年发布的数据，2020年全球有230万名女性被诊断出罹患乳癌。据上述同一消息来源称，截至2020年底，过去五年已有780万名女性被诊断出患有乳癌，使其成为世界上最常见的疾病。

此外，推动乳房重建市场成长的另一个主要因素是全球整容和再造手术数量的不断增加。例如，根据《整形外科统计报告（2020）》，2020年美国进行的整容手术总数为1560万例，其中整容手术230万例，微创手术1320万例。据同一消息来源称，2020 年进行了 680 万例重建手术（比 2019 年增长 3%）。此外，2020年，美国进行了193,073例乳房植入物，其中84%使用硅胶植入物，16%使用盐水植入物。因此，随着整容和重建手术的兴起，乳房再造的需求也会增加，从而带动整个乳房再造市场的成长。

因此，预计所有上述因素将共同推动 2024-2030 年预测期内乳房再造市场的整体成长。

然而，替代非手术技术的可用性和基于植入物的乳房重建的高成本预计将阻碍全球乳房重建市场的成长。

持续的 COVID-19 大流行对乳房重建市场产生了负面影响，因为与 COVID-19 患者相比，患有癌症和其他疾病的患者没有优先住院和择期手术。这对我产生了影响。封锁规定、人员短缺以及口罩和个人防护装备的短缺对乳房重建患者的住院产生了重大影响。然而，随着大规模疫苗接种、封锁规定的放鬆、择期手术的恢復、口罩、个人防护用品套件和工作人员的供应，乳房重建市场已恢復势头，预计在2024-2030 年预测期内将出现增长。

乳房再造市场区隔分析

在乳房重建市场的产品类型领域，预计到 2023 年，乳房植入物将占据重要的收入份额。乳房重建市场的主要成长动力包括对乳房植入物的需求不断增长，以提高全球女性的美学吸引力。乳房再造手术用于解决胸壁的先天性缺陷或畸形，并改变乳房的形状和大小。此外，乳房重建手术还可以帮助乳房切除术后恢復自然的乳房，或简单地增大乳房，对于乳房中没有大量脂肪组织、增加乳房体积的人来说是一个不错的选择。胸部，以及增加曲线。

因此，与用于乳房重建的乳房植入物相关的好处将增加其市场需求，并在预测期内推动整个乳房重建市场的成长。此外，越来越多的监管部门批准乳房重建产品也推动了市场成长。例如，2020 年 9 月，全球领先的乳房美容公司之一、强生医疗器材子公司 Mentor Worldwide LLC 宣布，美国食品药物管理局 (FDA) 已批准 22 岁及以上女性隆乳手术宣布批准MENTOR MemoryGel BOOSTTM 乳房植入物用于女性乳房重建。

本报告提供了全球乳房重建市场的研究和分析，包括市场规模和预测、驱动因素和挑战以及公司和产品概况。

推动乳房重建市场的因素
- 乳癌盛行率不断上升
- 整容和重建手术数量增加
- 人口老化、种族和族裔等因素推动乳房重建市场
- 采用先进技术的乳房再造产品的推出激增
乳房重建市场的限制与挑战
- 替代非手术技术的可用性
- 使用植入物进行乳房重建的成本高昂
乳房再造市场机遇
- 将3D列印技术融入乳房再造
- 全球乳房手术数量不断增加

第5章乳房重建市场波特五力分析

第6章COVID-19对乳房重建市场的影响分析

第7章乳房重建市场布局

依产品类型
- 隆乳手术
- 扩胸器
- 去细胞真皮基质
依形状
- 圆形
- 解剖学
按最终用户
- 医院
- 美容诊所
- 门诊手术中心
按地区
- 北美
- 欧洲
- 亚太地区
- 其他领域

第 8 章乳房重建市场：全球公司份额分析 - 3 至 5 家主要公司

第9章乳房重建市场公司及产品概况

Mentor Worldwide LLC
AbbVie Inc
IDEAL IMPLANT INCORPORATED
Sebbin
GC Aesthetics
POLYTECH Health & Aesthetics GmbH
Sientra Inc
Integra LifeSciences
Establishment Labs S.A
LABORATOIRES ARION
HansBioMed
Lattice Medical
CEREPLAS
AirXpanders
PMT Corporation
SILIMED
Technomed (India) Private Limited
Apex Medical Device Design LLC (DefyGravity)
Guangzhou Wanhe Plastic Material Co Ltd

第10章KOL观看次数

第 11 章专案方法

第 12 章关于 DelveInsight

第 13 章免责声明与联络我们

简介目录图表

Product Code: DIMDCL0283

Breast Reconstruction Market By Product Type (Breast Implants, Breast Expanders, And Acellular Dermal Matrix), By Shape (Round And Anatomical), By End-User (Hospitals, Cosmetology Clinics, And Ambulatory Surgical Centers), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of breast cancer and the increase in the number of cosmetic & reconstructive plastic surgeries

The global breast reconstruction market was valued at USD 554.50 million in 2023, growing at a CAGR of 6.54% during the forecast period from 2024 to 2030 to reach USD 810.14 million by 2030. The breast reconstruction market is witnessing positive growth owing to various factors such as the increasing prevalence of breast cancer, the increase in the number of cosmetic & reconstructive surgeries, the surge in the launch of technologically advanced breast reconstruction products, and the factors such as aging, race, & ethnicity drives the breast reconstruction demand. Therefore, the market for breast reconstruction is estimated to grow at a significant CAGR during the forecast period from 2024 to 2030.

Breast Reconstruction Market Dynamics:

One of the main drivers of the breast reconstruction market is the increasing prevalence of breast cancer globally. According to World Health Organization (WHO) data published in the year 2023, 2.3 million women worldwide were diagnosed with breast cancer in 2020. As per the same source mentioned above, by the end of 2020, 7.8 million women were diagnosed with breast cancer in the previous five years, making it the most common disease in the world.

Moreover, another key factor that is responsible for the growth of the breast reconstruction market is the increase in the number of cosmetic & reconstructive surgeries across the globe. For instance, according to the plastic surgery statistics report 2020, in America, there were 15.6 million total cosmetic procedures performed in the year 2020, of which 2.3 million were cosmetic surgical procedures and 13.2 million cosmetic procedures were minimally invasive. As per the same source, 6.8 million reconstructive procedures were performed in the year 2020 (a 3% increase from 2019). Further, in the year 2020, in America, there were 193,073 breast augmentations performed, of which silicone implants were utilized in 84% while saline implants were used in 16%. Therefore, with the increase in cosmetic & reconstructive surgeries, demand for breast reconstruction also increases, thereby driving the breast reconstruction overall market growth.

Therefore, all the factors mentioned above will collectively surge the overall growth of the breast reconstruction market during the forecast period from 2024-2030.

However, availability of the alternative non-surgical methods and the high cost of breast reconstruction using implants will hamper the global breast reconstruction market growth.

The ongoing Coronavirus disease 2019 (COVID-19) pandemic has negatively impacted the market for breast reconstruction as hospital admissions for patients suffering from cancers & other disorders as well as elective surgeries were not a priority in comparison to the patients suffering from COVID. Lockdown restrictions, lack of staff, and shortage of masks, and PPE kits made a huge impact on patient admissions in hospitals for breast reconstruction. However, with masses being vaccinated, lockdown restriction relaxation, resumption of elective surgeries, and availability of masks, PPE kits, and staff, the breast reconstruction market has picked momentum and is expected to grow during the forecast period from 2024-2030.

Breast Reconstruction Market Segment Analysis:

Breast Reconstruction Market by Product Type (Breast Implants, Breast Expanders, and Acellular Dermal Matrix), Shape (Round and Anatomical), End-User (Hospitals, Cosmetology Clinics, and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the by-product type segment of the breast reconstruction market, breast implants are expected to hold a significant revenue share in the year 2023. The key attributes driving the growth of the breast reconstruction market includes the rising demand of breast implants among the women across the globe as to enhance their aesthetic appeal. Breast reconstructive surgery address congenital defects and deformities of the chest wall, it is also used to change shape as well as size of the breast. Further, breast reconstructive surgery also helps to restore a natural-looking breast following a mastectomy, or simply to enlarge the breasts and it's a good alternative for people who don't have a lot of fatty tissue on breast, and adds volume as well as curves to the breast.

Therefore, the benefits associated with breast implants for breast reconstruction would increase their demand in the market, which will drive the growth of the overall breast reconstruction market during the forecast period. Further, the increase in the regulatory approvals for breast reconstruction products is also driving market growth. For instance, in September 2020, Mentor Worldwide LLC, the world's leading breast aesthetics company and a subsidiary of Johnson & Johnson Medical Devices, announced that the US Food and Drug Administration (FDA) has approved the MENTOR® MemoryGel BOOSTTM breast implant for breast augmentation in women over the age of 22 and for breast reconstruction in women of all ages.

Therefore, such type of development activities in the breast implant segment for breast reconstruction would result in driving the demand for breast reconstruction which in turn would provide a conductive growth for the overall breast reconstruction market during the forecast 2024-2030.

North America is expected to dominate the overall Breast Reconstruction Market:

Among all the regions, North America is expected to dominate the global breast reconstruction market in the year 2023 and is expected to do the same during the forecast period from 2024-2030. Factors such as aging, race, and ethnicity drive breast reconstruction demand, and the surge in the launch of technologically advanced breast reconstruction products are expected to increase the demand for breast reconstructions in the North America market.

According to the American Cancer Society data published in January 2022, breast cancer rates vary between racial and ethnic groupings in the United States. According to the latest statistics, black women are diagnosed at a younger age (60) than white women (63), and they have a higher death rate. This might be because one in every five black women has triple-negative breast cancer, which is greater than any other racial/ethnic group. As per the source mentioned above, black women have a significant risk of having cancer before the age of 40 years.

Furthermore, the most significant risk factor for breast cancer is age. People's risks of having cancer increase as they grow older. According to the American Cancer Society, data published in the year 2023, in the United States, one out of every eight women under the age of 45 will acquire invasive breast cancer by the end of the year 2022, and two out of every three invasive breast cancers will be diagnosed in women 55 and older.

Moreover, according to the Breast Cancer Organization data published in the year 2023, more than 3.8 million women in the United States had a history of breast cancer as of January 2022. As per the aforementioned source, by the end of the year 2022, 2,710 additional instances of invasive breast cancer in men are predicted to be detected.

Additionally, another factor such as the surge in the launch of technologically advanced breast reconstruction products will also drive the breast reconstruction market. For instance, in May 2022, GC Aesthetics Inc., a privately-held medical technology company providing aesthetic solutions, announced the launch of its next-generation breast implants, PERLE(TM). It is a highly innovative line of smooth breast implants that features a proprietary surface technology (BioQ(TM)), GCA's industry-leading gel technology (Emunomic(TM) Breast Tissue Dynamic Gel), and an improved version of the safety measures that have underpinned GCA's long-term excellent safety record.

Therefore, the interplay of the factors mentioned above for breast reconstruction would provide a conducive growth environment for the North American region in the breast reconstruction market.

Breast Reconstruction Market Key Players:

Some of the key market players operating in the breast reconstruction market include Mentor Worldwide LLC, AbbVie Inc, IDEAL IMPLANT INCORPORATED, Sebbin, GC Aesthetics, POLYTECH Health & Aesthetics GmbH, Sientra Inc, Integra LifeSciences, Establishment Labs S.A, LABORATOIRES ARION, HansBioMed, Lattice Medical, CEREPLAS, AirXpanders, PMT Corporation, SILIMED, DPS Technology Development Ltd, Technomed (India) Private Limited, Apex Medical Device Design LLC (DefyGravity), Guangzhou Wanhe Plastic Material Co Ltd and among others

Recent Developmental Activities in the Breast Reconstruction:

In September 2020, POLYTECH Health & Aesthetics GmbH, a global pioneer in breast aesthetics, expanded its B-Lite® portfolio, which includes the world's first and only lightweight breast implants. B-Lite® breast implants offer several benefits to women, including faster recovery & less post-operative discomfort, allowing patients to return to their normal routine sooner. B-Lite® with MESMO® fine-texturing surface and B-Lite® with the distinctive Microthane® shell coating are among the new forms and surfaces in the enlarged offering

In August 2020, Sientra, Inc, a diversified global medical aesthetics company, announced the approval from Japan's Pharmaceutical and Medical Device Agency ("PDMA") to market its entire OPUS line of breast implants in Japan.

In November 2019, BellaSano, German additive manufacturing start-up signed a long term agreement with Evonik, a chemical company's RESOMER bioresorbable polymer to create a new breast implant technology. RESOMER will be used in BellaSeno's 3D-printed Senella breast scaffold. The product is intended to be used for breast reconstruction, augmentation, and revision surgery. As it is gradually absorbed by the body and the natural breast tissue replaces it.

Key Takeaways from the Breast Reconstruction Market Report Study:

Market size analysis for the current breast reconstruction market (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the breast reconstruction market
Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint venture happened for last 3 years
Key companies dominating the global breast reconstruction
Various opportunities available for the other competitor in the breast reconstruction market space.
What are the top performing segments in 2023? How these segments will perform in 2030.
Which are the top-performing regions and countries in the current breast reconstruction market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for breast reconstruction market growth in the coming future?

Target Audience who can be benefited from this Breast Reconstruction Market Report Study

Breast reconstruction providers
Research organizations and consulting companies
Breast reconstruction-related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and traders dealing in breast reconstruction
Various end-users who want to know more about the breast reconstruction market and latest technological developments in the breast reconstruction

Frequently Asked Questions for Breast Reconstruction:

1. What is Breast Reconstruction?

Breast reconstruction is a surgical procedure that reconstructs the form and appearance of a breast, most often in women who have had breast cancer surgery. The objective is to rebuild a natural-looking breast utilizing autologous tissue, artificial implants, or a mix of both.

2. What is the market for Global Breast Reconstruction?

The global breast reconstruction market was valued at USD 554.50 million in 2023, growing at a CAGR of 6.54% during the forecast period from 2024 to 2030 to reach USD 810.14 million by 2030.

3. What are the drivers for the Global Breast Reconstruction market?

The breast reconstruction market is witnessing positive market growth owing to the factors such as, such as the increasing prevalence of breast cancer, the increase in the number of cosmetic & reconstructive surgeries, the surge in the launch of technologically advanced breast reconstruction products, and the factors such as aging, race, & ethnicity will also contribute in the growth of breast cancer which drives the breast reconstruction product demand.

4. Who are the key players operating in the Breast Reconstruction market?

5. Which region has the highest share in Breast Reconstruction Market?

North America is expected to dominate the global breast reconstruction market. Factors contributing to the growth are the surge in the launch of technologically advanced breast reconstruction products, and the factors such as aging, race, & ethnicity drive the breast reconstruction demand, contributes to the growth of the breast reconstruction market in the North America region.

1.Breast Reconstruction Market Report Introduction

2.Breast Reconstruction Market Executive Summary

2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment
2.4. Financial Benchmarking

3. Regulatory Analysis

3.1. The US
3.2. Europe
3.3. Japan
3.4. China

4. Breast Reconstruction Market Key Factors Analysis

4.1. Breast Reconstruction Market Drivers
- 4.1.1. The Increasing Prevalence of Breast Cancer
- 4.1.2. The Increase in the Number of Cosmetic & Reconstructive Surgeries
- 4.1.3. The Factors such as Aging, Race, & Ethnicity Drives the Breast Reconstruction Market
- 4.1.4. The Surge in the Launch of Technologically Advanced Breast Reconstruction Products
4.2. Breast Reconstruction Market Restraints And Challenges
- 4.2.1. The Availability of the Alternative Non-Surgical Methods
- 4.2.2. The High Cost of Breast Reconstruction Using Implants
4.3. Breast Reconstruction Market Opportunities
- 4.3.1. The Integration of 3D Printing Technology in the Breast Reconstruction
- 4.3.2. The Increase in Number of Breast Surgeries Worldwide

5. Breast Reconstruction Market Porter's Five Forces Analysis

5.1. Bargaining Power of Suppliers
5.2. Bargaining Power of Consumers
5.3. Threat of New Entrants
5.4. Threat of Substitutes
5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Breast Reconstruction Market

7. Breast Reconstruction Market Layout

7.1. By Product Type
- 7.1.1. Breast Implants
- 7.1.2. Breast Expanders
- 7.1.3. Acellular Dermal Matrix
7.2. By Shape
- 7.2.1. Round
- 7.2.2. Anatomical
7.3. By End User
- 7.3.1. Hospitals
- 7.3.2. Cosmetology Clinics
- 7.3.3. Ambulatory Surgical Centers
7.4. By Geography
- 7.4.1. North America
  - 7.4.1.1. United States Breast Reconstruction Market Size in USD Million (2021-2030)
  - 7.4.1.2. Canada Breast Reconstruction Market Size in USD million (2021-2030)
  - 7.4.1.3. Mexico Breast Reconstruction Market Size in USD million (2021-2030)
- 7.4.2. Europe
  - 7.4.2.1. France Breast Reconstruction Market Size in USD million (2021-2030)
  - 7.4.2.2. Germany Breast Reconstruction Market Size in USD million (2021-2030)
  - 7.4.2.3. United Kingdom Breast Reconstruction Market Size in USD million (2021-2030)
  - 7.4.2.4. Italy Breast Reconstruction Market Size in USD million (2021-2030)
  - 7.4.2.5. Spain Breast Reconstruction Market Size in USD million (2021-2030)
  - 7.4.2.6. Russia Breast Reconstruction Market Size in USD million (2021-2030)
  - 7.4.2.7. Rest of Europe Breast Reconstruction Market Size in USD million (2021-2030)
- 7.4.3. Asia-Pacific
  - 7.4.3.1. China Breast Reconstruction Market Size in USD million (2021-2030)
  - 7.4.3.2. Japan Breast Reconstruction Market Size in USD million (2021-2030)
  - 7.4.3.3. India Breast Reconstruction Market Size in USD million (2021-2030)
  - 7.4.3.4. Australia Breast Reconstruction Market Size in USD million (2021-2030)
  - 7.4.3.5. South Korea Breast Reconstruction Market Size in USD million (2021-2030)
  - 7.4.3.6. Rest of Asia Pacific Breast Reconstruction Market Size in USD million (2021-2030)
- 7.4.4. Rest of the World (RoW)
  - 7.4.4.1. Middle East Breast Reconstruction Market Size in USD million (2021-2030)
  - 7.4.4.2. Africa Breast Reconstruction Market Size in USD million (2021-2030)
  - 7.4.4.3. South America Breast Reconstruction Market Size in USD million (2021-2030)

8. Breast Reconstruction market Global Company Share Analysis - Key 3-5 Companies

9. Breast Reconstruction Market Company and Product Profiles

9.1. Mentor Worldwide LLC
- 9.1.1. Company Overview
- 9.1.2. Company Snapshot
- 9.1.3. Financial Overview
- 9.1.4. Product Listing
- 9.1.5. Entropy
9.2. AbbVie Inc
- 9.2.1. Company Overview
- 9.2.2. Company Snapshot
- 9.2.3. Financial Overview
- 9.2.4. Product Listing
- 9.2.5. Entropy
9.3. IDEAL IMPLANT INCORPORATED
- 9.3.1. Company Overview
- 9.3.2. Company Snapshot
- 9.3.3. Financial Overview
- 9.3.4. Product Listing
- 9.3.5. Entropy
9.4. Sebbin
- 9.4.1. Company Overview
- 9.4.2. Company Snapshot
- 9.4.3. Financial Overview
- 9.4.4. Product Listing
- 9.4.5. Entropy
9.5. GC Aesthetics
- 9.5.1. Company Overview
- 9.5.2. Company Snapshot
- 9.5.3. Financial Overview
- 9.5.4. Product Listing
- 9.5.5. Entropy
9.6. POLYTECH Health & Aesthetics GmbH
- 9.6.1. Company Overview
- 9.6.2. Company Snapshot
- 9.6.3. Financial Overview
- 9.6.4. Product Listing
- 9.6.5. Entropy
9.7. Sientra Inc
- 9.7.1. Company Overview
- 9.7.2. Company Snapshot
- 9.7.3. Financial Overview
- 9.7.4. Product Listing
- 9.7.5. Entropy
9.8. Integra LifeSciences
- 9.8.1. Company Overview
- 9.8.2. Company Snapshot
- 9.8.3. Financial Overview
- 9.8.4. Product Listing
- 9.8.5. Entropy
9.9. Establishment Labs S.A
- 9.9.1. Company Overview
- 9.9.2. Company Snapshot
- 9.9.3. Financial Overview
- 9.9.4. Product Listing
- 9.9.5. Entropy
9.10. LABORATOIRES ARION
- 9.10.1. Company Overview
- 9.10.2. Company Snapshot
- 9.10.3. Financial Overview
- 9.10.4. Product Listing
- 9.10.5. Entropy
9.11. HansBioMed
- 9.11.1. Company Overview
- 9.11.2. Company Snapshot
- 9.11.3. Financial Overview
- 9.11.4. Product Listing
- 9.11.5. Entropy
9.12. Lattice Medical
- 9.12.1. Company Overview
- 9.12.2. Company Snapshot
- 9.12.3. Financial Overview
- 9.12.4. Product Listing
- 9.12.5. Entropy
9.13. CEREPLAS
- 9.13.1. Company Overview
- 9.13.2. Company Snapshot
- 9.13.3. Financial Overview
- 9.13.4. Product Listing
- 9.13.5. Entropy
9.14. AirXpanders
- 9.14.1. Company Overview
- 9.14.2. Company Snapshot
- 9.14.3. Financial Overview
- 9.14.4. Product Listing
- 9.14.5. Entropy
9.15. PMT Corporation
- 9.15.1. Company Overview
- 9.15.2. Company Snapshot
- 9.15.3. Financial Overview
- 9.15.4. Product Listing
- 9.15.5. Entropy
9.16. SILIMED
- 9.16.1. Company Overview
- 9.16.2. Company Snapshot
- 9.16.3. Financial Overview
- 9.16.4. Product Listing
- 9.16.5. Entropy
9.17. DPS Technology Development Ltd
- 9.17.1. Company Overview
- 9.17.2. Company Snapshot
- 9.17.3. Financial Overview
- 9.17.4. Product Listing
- 9.17.5. Entropy
9.18. Technomed (India) Private Limited
- 9.18.1. Company Overview
- 9.18.2. Company Snapshot
- 9.18.3. Financial Overview
- 9.18.4. Product Listing
- 9.18.5. Entropy
9.19. Apex Medical Device Design LLC (DefyGravity)
- 9.19.1. Company Overview
- 9.19.2. Company Snapshot
- 9.19.3. Financial Overview
- 9.19.4. Product Listing
- 9.19.5. Entropy
9.20. Guangzhou Wanhe Plastic Material Co Ltd
- 9.20.1. Company Overview
- 9.20.2. Company Snapshot
- 9.20.3. Financial Overview
- 9.20.4. Product Listing
- 9.20.5. Entropy